Driehaus Capital Management LLC Legend Biotech Corp Transaction History

Driehaus Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$57.25 - $69.74 $1.61 Million - $1.96 Million	28,103 Added 13.64%	234,206 $14.1 Million
Q3 2023 Nov 14, 2023	BUY	$63.16 - $76.5 $13 Million - $15.8 Million	206,103 New	206,103 $13.8 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $55.0 $10.6 Million - $17.4 Million	317,117 New	317,117 $17.4 Million
Q3 2020 Nov 16, 2020	SELL	$27.5 - $39.61 $10 Million - $14.5 Million	-365,174 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$36.1 - $42.56 $13.2 Million - $15.5 Million	365,174 New	365,174 $15.5 Million

225

74.3M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.85B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.